Pilot and feasibility clinical trials in diabetes, endocrine and metabolic diseases, National Institutes of Health

The National Institute of Diabetes and Digestive and Kidney Diseases invites applications for its pilot and feasibility clinical trials in diabetes, and endocrine and metabolic diseases (R21) funding opportunity announcement. This announcement supports pilot and feasibility trials conducted in humans that will lay the foundation for larger clinical trials related to the prevention or treatment of diabetes or selected endocrine and genetic metabolic diseases.

Deadline: 16 June 2015

More information is available on the NIH grants website.